Finance Home - My Yahoo - Yahoo! - Help

Saturday, November 28, 2009, 3:36PM ET - U.S. Markets Closed. Dow  1.48% Nasdaq  1.73%

Seattle Genetics Inc. (SGEN)

On Nov 27: 9.39   0.24 (2.49%)

MORE ON SGEN

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Competitors Get Competitors for:
DIRECT COMPETITOR COMPARISON   SGEN Pvt1 IMGN Pvt2 Industry Market Cap: 943.99M N/A 465.04M N/A 100.26M Employ­ees: 261 N/A 210 4881 65 Qtrly Rev Growth (yoy): 44.20% N/A -49.40% N/A 19.70% Revenue (ttm): 40.26M N/A 24.96M 52.30M1 14.05M Gross Margin (ttm): -217.41% N/A -85.22% N/A 65.67% EBITDA (ttm): -100.69M N/A -28.47M N/A -12.30M Oper Margins (ttm): -258.38% N/A -134.15% N/A -137.11% Net Income (ttm): -100.16M N/A -34.92M -38.50M1 N/A EPS (ttm): -1.168 N/A -0.663 N/A -0.32 P/E (ttm): N/A N/A N/A N/A 16.37 PEG (5 yr expected): N/A N/A N/A N/A 1.31 P/S (ttm): 24.04 N/A 19.04 N/A 9.43 Pvt1 = Genzyme Oncology (privately held) IMGN = Immunogen Inc. Pvt2 = Medarex, Inc. (privately held) Industry = Biotechnology 1 = As of 2008   BIOTECHNOLOGY COMPANIES RANKED BY SALES   Company Symbol Price Change Market Cap P/E Amgen Inc. AMGN 56.50 -1.02% 57.19B 12.32 Genentech, Inc. Private - View Profile Biogen Idec Inc. BIIB 46.92 -1.12% 13.57B 15.70 Genzyme Corp. GENZ 51.07 -0.87% 13.55B 29.12 Merck Serono S.A. Private - View Profile Chiron Corporation Private - View Profile Gilead Sciences Inc. GILD 46.56 -0.89% 41.90B 18.00 MedImmune, Inc. Private - View Profile Life Technologies Corporation LIFE 49.95 -1.85% 8.91B 1019.39 Teva Pharmaceutical Industries Limited TEVA 52.88 -0.53% 46.59B 48.38 View Biotechnology Industry Center GENERIC DRUGMAKERS RANKED BY SALES   Company Symbol Price Change Market Cap P/E Sandoz International GmbH Private - View Profile Watson Pharmaceuticals Inc. WPI 36.96 -2.25% 3.92B 19.05 Barr Pharmaceuticals, Inc. Private - View Profile King Pharmaceuticals Inc. KG 11.95 -1.08% 2.97B N/A Ranbaxy Laboratories Limited Private - View Profile Mylan, Inc. MYL 18.01 -1.53% 5.50B 110.49 Pfizer Inc. PFE 18.25 -1.83% 147.27B 15.16 Johnson & Johnson JNJ 62.89 -0.65% 173.52B 13.73 GlaxoSmithKline plc GSK 42.26 -1.45% 107.13B 13.21 Sanofi-Aventis SNY 38.43 -2.61% 100.35B N/A View Biotechnology Industry Center DRUGMAKERS RANKED BY SALES   Company Symbol Price Change Market Cap P/E Novartis AG NVS 55.38 -0.84% 125.78B 16.58 RHHBY.PK 41.46 -1.96% N/A N/A AstraZeneca plc AZN 45.29 -2.35% 65.67B 9.09 Abbott Laboratories ABT 54.08 -0.61% 83.65B 14.65 Bristol-Myers Squibb Co. BMY 25.38 -1.05% 50.28B 13.13 View Biotechnology Industry Center NEWS ON DIRECT COMPETITORS   • IMGN Biotech Stock Mailbag: Targacept Fri 6:00am - at TheStreet.com • IMGN ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition Tue, Nov 24 - Business Wire • IMGN UPDATE - ImmunoGen licenses anti-cancer technology to Amgen Thu, Nov 19 - at Reuters • IMGN ImmunoGen licenses technology to Amgen for $1M Thu, Nov 19 - AP • IMGN ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Company's TAP Technology Thu, Nov 19 - Business Wire All Headlines for these symbols... Need more? Get unbiased, in-depth information on public and private companies worldwide from Hoover's Online.
Add to Portfolio     Set Alert     Email to a Friend Get Competitors for Another Symbol: Symbol Lookup • Stock Screener • Sector Analysis